To evaluate the Fibrosis (FIB)-4 index as a predictor of major liver-related events (LRE) and liver-related death (LRD) in human immunodeficiency virus (HIV) type-1 patients initiating combination antiretroviral therapy (cART).
Mussini, C., Lorenzini, P., Puoti, M., Lichtner, M., Lapadula, G., Di Giambenedetto, S., Antinori, A., Madeddu, G., Cozzi Lepri, A., D'Arminio Monforte, A., De Luca, A., Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus, <<PLOS ONE>>, 2015; 10 (12): e0140877-e0140877. [doi:10.1371/journal.pone.0140877] [http://hdl.handle.net/10807/70740]
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus
Di Giambenedetto, Simona;De Luca, Andrea
2015
Abstract
To evaluate the Fibrosis (FIB)-4 index as a predictor of major liver-related events (LRE) and liver-related death (LRD) in human immunodeficiency virus (HIV) type-1 patients initiating combination antiretroviral therapy (cART).
| File | Dimensione | Formato | |
|---|---|---|---|
|
unpaywall-bitstream--1049517769.pdf
accesso aperto
Tipologia file ?:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
352.87 kB
Formato
Adobe PDF
|
352.87 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
